Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000342
Status:
COMPLETED
Last Update Posted:
2017-01-16
First Post:
1999-09-20
Brief Title:
Risperidone for the Treatment of Cocaine Dependence - 7
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Risperidone for the Treatment of Cocaine Dependence
Status:
COMPLETED
Status Verified Date:
1997-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate clinical safety and pharmacological efficacy in the treatment of cocaine dependence to evaluate impact of treatment on craving and to correlate evidence of baseline neurotoxic damage of cocaine with treatment outcome and clinical side-effects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Y01-3-0010-7 | None | None | None |